Niche Transdermal ProSolus specializes in high-barrier-to-entry transdermal drug delivery patches, indicating demand for specialized contract development and manufacturing services in a tight regulatory and technical space.

Strategic Acquisition Recent acquisition by Canoa Supply suggests growth momentum and potential integration with larger pharma networks, presenting joint venture or partnership opportunities for expanded product portfolios and distribution.

Small but Agile With a lean team and revenue in the lower multi-millions, there is opportunity to offer scalable, high-margin CDMO engagements, pilot programs, and rapid-development contracts for early-stage transdermal products.

Innovative Formulations Emphasis on polymer/excipient optimization for improved skin absorption positions ProSolus as a candidate for strategic collaborations on novel patches, bioavailability enhancements, and customized excipient sourcing.

Digital & Marketing Digital footprint across Google Ads, analytics, and marketing platforms indicates openness to targeted outreach, lead generation programs, and demand-generation partnerships to expand customer base in pharma and biotech segments.